Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-20-041363

Options or other derivatives

  • Director acquired 35,006 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Gangolli Julian S · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-07-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +35,006 $0.99 $34,491 35,006 D
Loading xslF345X03/doc4.xml…